{
  "id": 5494146,
  "title": "New Zealand drugs regulator approves use of MDMA to treat severe PTSD",
  "url": "https://urgent.news/2026/09/04/new-zealand-drugs-regulator-approves-use-of-mdma-to-treat-severe-ptsd-5494146",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-04T04:27:13.000Z",
  "source": {
    "name": "Guardian Health",
    "slug": "guardian-health",
    "url": "https://www.theguardian.com/world/2026/sep/04/new-zealand-approves-mdma-to-treat-severe-ptsd"
  },
  "original_language": "en",
  "account": null,
  "summary": "New Zealand decision follows Australian approval in 2023 of psychedelics to treat PTSD and treatment-resistant depression Two psychiatrists in New Zealand won approval on Friday to prescribe pharmaceutical-grade MDMA to people with severe post-traumatic stress disorder (PTSD). The move by New Zealand’s pharmaceutical regulatory body Medsafe makes the country only the second worldwide to approve…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Guardian Science",
        "title": "New Zealand drugs regulator approves use of MDMA to treat severe PTSD",
        "url": "https://urgent.news/2026/09/04/new-zealand-drugs-regulator-approves-use-of-mdma-to-treat-severe-ptsd",
        "published": "2026-09-04T04:27:13.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}